1st Edition

Mild to Moderate and Moderate to Severe Psoriasis (Set)




ISBN 9781482215021
Published March 21, 2014 by CRC Press
626 Pages

USD $230.00

Prices & shipping based on shipping country


Preview

Book Description

Edited by an expert editorial team from leading dermatology centers, this set consists of two books: Mild to Moderate Psoriasis, Third Edition and Moderate to Severe Psoriasis, Fourth Edition. Using a practical and problem-focused approach, these updated texts equip dermatologists, family practitioners, and internists with a state-of-the-art guide to the clinical management of all forms of psoriasis. The set provides up-to-date treatment strategies for optimum patient management.

Table of Contents

Mild to Moderate Psoriasis, Third Edition

Introduction to Mild-to-Moderate Psoriasis
General Approach to Psoriasis Treatment
General Guidelines for Administration of Topical Agents in the Treatment of Mild-To-Moderate Psoriasis
Topical Corticosteroids
Vitamin D3 analogs
Fixed Dose Corticosteroid/Calcipotriene Combination Therapy
Topical Tazarotene
Topical Calcineurin Inhibitors
Treatment of Mild-To-Moderate Psoriasis with Coal Tar, Anthralin, Salicyclic Acid, and Lactic Acid
Phototherapy and Laser for the Treatment of Mild-To-Moderate Psoriasis
Topical Sequential Therapy of Psoriasis
Combination Therapy
Palmoplantar Psoriasis
Scalp Psoriasis
Inverse Psoriasis
Psoriasis of the Nails

Moderate to Severe Psoriasis, Fourth Edition

An Overview of Psoriasis
Evaluating Psoriasis in Patients
Topical Agents in the Treatment of Moderate to Severe Psoriasis
The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO
Systemic and Topical PUVA Therapy
Therapy of Moderate-To-Severe PSO with MTX
Systemic Retinoids
Cyclosporine in the treatment of severe pSO
Combination, Rotational, and Sequential Therapies
Pediatric Psoriasis
Psoriatic Arthritis
Etanercept for Treatment of Psoriasis
Adalimumab in the treatment of psoriasis
Infliximab in the treatment of PSO
New Agents: IL-17, JAK kinase
Ustekinumab
Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of Pso
The Immunomodulatory/Immunosuppressive Classification System
Goeckerman and Ingram Day Treatment Program

...
View More

Editor(s)

Biography

Koo, John; Levin, Ethan; Leon, Argentina; Wu, Jashin; Lebwohl, Mark; Gottlieb, Alice